Phenyl-quinoline derivatives as lead structure of cholinesterase inhibitors with potency to reduce the GSK-3β level targeting Alzheimer's disease
Milad Noori(Iran University of Science and Technology), Aida Iraji(Shiraz University of Medical Sciences), Bagher Larijani(Tehran University of Medical Sciences), Haleh Hamedifar(Biotechnology Research Center), Sajedeh Safapoor(Tehran University of Medical Sciences), Cambyz Irajie(Shiraz University of Medical Sciences), Romina Tanideh(Shiraz University of Medical Sciences), Navid Dastyafteh(Iran University of Science and Technology), Mahintaj Dara(Shiraz University), Shahrzad Javanshir(Iran University of Science and Technology), Hossein Rastegar(Iran Nanohealth Committee Food and Drug Organization), Kamiar Zomorodian(Shiraz University of Medical Sciences), Mohammad Mahdavi(Shaheed Rajaei Cardiovascular Medical and Research Center), Shahrokh Zare(Shiraz University of Medical Sciences), Minoo Khalili Ghomi(Tehran University of Medical Sciences), Nikoo Panahi(Tehran University of Medical Sciences), Mir Hamed Hajimiri(Biotechnology Research Center)
Cited by 24
Related Papers
The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report
|The Lancet|2019|3k
Gut microbiota-derived metabolites in obesity: a systematic review
|Bioscience of Microbiota Food and Health|2020|178
The challenge for global health systems in preventing and managing obesity
|Obesity Reviews|2019|128
The assessment of osteoporosis risk factors in Iranian women compared with Indian women
|BMC Musculoskeletal Disorders|2008|126
Machine Learning: A New Prospect in Multi-Omics Data Analysis of Cancer
|Frontiers in Genetics|2022|119